Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 May;67(5):893–897. doi: 10.1038/bjc.1993.167

Inhibition by a new bisphosphonate (YM175) of bone resorption induced by the MBT-2 tumour of mice.

R Nemoto 1, Y Nishijima 1, K Uchida 1, K Koiso 1
PMCID: PMC1968426  PMID: 8494721

Abstract

A new bisphosphonate, disodium dihydrogen (cycloheptylamino) methylene bisphosphonate monohydrate (YM175), was compared with 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (AHPrBP) and 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) in terms of its effect on tumour induced osteolysis using a bladder tumour in mice (MBT-2). The method consisted of inoculating tumour cells subcutaneously (SC) over the calvaria in mice, resulting in a local tumour causing fragmentation of the bone. The compounds were active not only when administered preventively before establishment of bone resorption, but also in an inhibitory fashion once the variables were already under the influence of the tumour. This osteolysis was evaluated by measuring the increased area of bone resorption in reduced opacity to radiograph and histology. The results showed the following sequence of potency: YM175 > AHPrBP = HEBP. This inhibition was obtained with no apparent effect on the growth of the MBT-2 tumour. YM175 appears to be an interesting new bisphosphonate with possible clinical application.

Full text

PDF
893

Images in this article

895Figure 1
on p.895

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fleisch H., Felix R. Diphosphonates. Calcif Tissue Int. 1979 Apr 17;27(2):91–94. doi: 10.1007/BF02441167. [DOI] [PubMed] [Google Scholar]
  2. Fleisch H., Russell R. G., Francis M. D. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science. 1969 Sep 19;165(3899):1262–1264. doi: 10.1126/science.165.3899.1262. [DOI] [PubMed] [Google Scholar]
  3. Galasko C. S., Bennett A. Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins. Nature. 1976 Oct 7;263(5577):508–510. doi: 10.1038/263508a0. [DOI] [PubMed] [Google Scholar]
  4. Jung A., Bornand J., Mermillod B., Edouard C., Meunier P. J. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat. Cancer Res. 1984 Jul;44(7):3007–3011. [PubMed] [Google Scholar]
  5. Jung A., Mermillod B., Barras C., Baud M., Courvoisier B. Inhibition by two diphosphonates of bone lysis in tumor-conditioned media. Cancer Res. 1981 Aug;41(8):3233–3237. [PubMed] [Google Scholar]
  6. Morton A. R., Howell A. Bisphosphonates and bone metastases. Br J Cancer. 1988 Nov;58(5):556–557. doi: 10.1038/bjc.1988.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nemoto R., Kanoh S., Koiso K., Harada M. Establishment of a model to evaluate inhibition of bone resorption induced by human prostate cancer cells in nude mice. J Urol. 1988 Oct;140(4):875–879. doi: 10.1016/s0022-5347(17)41848-9. [DOI] [PubMed] [Google Scholar]
  8. Nemoto R., Kanoh S., Koiso K., Harada M. Tumor-bone interaction induced by transplantable human tumors in nude mice. Cancer. 1988 Oct 1;62(7):1310–1316. doi: 10.1002/1097-0142(19881001)62:7<1310::aid-cncr2820620712>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  9. Nemoto R., Satou S., Mochizuki T., Okabe K. Response of MBT-2 bladder carcinoma-induced osteolysis to various agents. Cancer. 1992 May 1;69(9):2316–2321. doi: 10.1002/1097-0142(19920501)69:9<2316::aid-cncr2820690919>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  10. Nemoto R., Uchida K., Tsutsumi M., Koiso K., Satoh T. Bone resorption induced by transplanted bladder tumor (MBT-2) in mice. J Urol. 1988 Mar;139(3):650–652. doi: 10.1016/s0022-5347(17)42552-3. [DOI] [PubMed] [Google Scholar]
  11. Nemoto R., Uchida K., Tsutsumi M., Koiso K., Satou S., Satou T. A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium. J Cancer Res Clin Oncol. 1987;113(6):539–543. doi: 10.1007/BF00390862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pollard M., Luckert P. H. Effects of dichloromethylene diphosphonate on the osteolytic and osteoplastic effects of rat prostate adenocarcinoma cells. J Natl Cancer Inst. 1985 Nov;75(5):949–954. doi: 10.1093/jnci/75.5.949. [DOI] [PubMed] [Google Scholar]
  13. Soloway M. S. Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res. 1977 Aug;37(8 Pt 2):2918–2929. [PubMed] [Google Scholar]
  14. van Holten-Verzantvoort A. T., Bijvoet O. L., Cleton F. J., Hermans J., Kroon H. M., Harinck H. I., Vermey P., Elte J. W., Neijt J. P., Beex L. V. Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet. 1987 Oct 31;2(8566):983–985. doi: 10.1016/s0140-6736(87)92555-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES